Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Rebiotix Announces First Patient Enrolled in RBX2660 Phase 3 Clinical Trial

americanpharmaceuticalreviewAugust 08, 2017

Tag: Rebiotix , clinical trial , FDA

PharmaSources Customer Service